CAPPELLINI, Alessandra
 Distribuzione geografica
Continente #
NA - Nord America 2.094
EU - Europa 1.998
AS - Asia 1.306
SA - Sud America 97
AF - Africa 18
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 6
Totale 5.534
Nazione #
US - Stati Uniti d'America 2.068
IE - Irlanda 530
SG - Singapore 462
CN - Cina 427
SE - Svezia 357
DE - Germania 261
UA - Ucraina 239
RU - Federazione Russa 223
IT - Italia 172
TR - Turchia 159
HK - Hong Kong 100
BR - Brasile 76
FI - Finlandia 69
GB - Regno Unito 62
VN - Vietnam 55
IN - India 30
BD - Bangladesh 23
BE - Belgio 20
FR - Francia 14
EU - Europa 13
PL - Polonia 13
CA - Canada 12
AT - Austria 10
MX - Messico 9
NL - Olanda 8
IQ - Iraq 7
EC - Ecuador 6
JP - Giappone 6
ZA - Sudafrica 6
AU - Australia 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
DK - Danimarca 4
PY - Paraguay 4
VE - Venezuela 4
AL - Albania 3
AR - Argentina 3
ES - Italia 3
KE - Kenya 3
KZ - Kazakistan 3
MA - Marocco 3
PK - Pakistan 3
RO - Romania 3
AE - Emirati Arabi Uniti 2
CL - Cile 2
CO - Colombia 2
CZ - Repubblica Ceca 2
IL - Israele 2
JO - Giordania 2
LU - Lussemburgo 2
MY - Malesia 2
OM - Oman 2
PA - Panama 2
SC - Seychelles 2
TH - Thailandia 2
XK - ???statistics.table.value.countryCode.XK??? 2
CH - Svizzera 1
CR - Costa Rica 1
EG - Egitto 1
GA - Gabon 1
GE - Georgia 1
GR - Grecia 1
HN - Honduras 1
HU - Ungheria 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LY - Libia 1
MM - Myanmar 1
NI - Nicaragua 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PS - Palestinian Territory 1
QA - Qatar 1
TN - Tunisia 1
Totale 5.534
Città #
Dublin 530
Chandler 366
Singapore 256
Jacksonville 181
Izmir 150
San Jose 144
The Dalles 123
Ashburn 118
Hong Kong 99
Rome 95
Boardman 89
Ann Arbor 79
Wilmington 77
Dallas 74
Nanjing 73
Beijing 63
Woodbridge 62
Moscow 57
Hefei 47
Brooklyn 46
Lawrence 46
Princeton 46
New York 29
Ogden 29
Nanchang 28
Council Bluffs 27
Brandenburg 25
Bologna 23
Helsinki 23
Los Angeles 21
Santa Clara 21
Brussels 20
Dearborn 19
Munich 17
Changsha 16
Dong Ket 16
Ho Chi Minh City 16
Milan 15
Orem 15
Des Moines 14
Inglewood 14
San Francisco 14
Jiaxing 13
Orange 13
Tianjin 13
Hebei 12
Kunming 12
Falls Church 11
Hanoi 11
Warsaw 11
Seattle 10
Shenyang 9
São Paulo 9
Cassino 8
Verona 8
Chennai 7
Hangzhou 7
Lanzhou 7
Salerno 7
Vienna 7
Boston 6
Fairfield 6
Pune 6
Amsterdam 5
Baghdad 5
Haikou 5
Manchester 5
Montreal 5
Nuremberg 5
Tashkent 5
Ankara 4
Chicago 4
Frankfurt am Main 4
London 4
Ningbo 4
Tokyo 4
Toronto 4
Turku 4
Asunción 3
Atlanta 3
Caracas 3
Changchun 3
Copenhagen 3
Denver 3
Hanover 3
Johannesburg 3
Norwalk 3
Tappahannock 3
Zhengzhou 3
Almaty 2
Amman 2
Auburn Hills 2
Bengaluru 2
Cambridge 2
Canberra 2
Clifton 2
Guangzhou 2
Houston 2
Jinan 2
Katowice 2
Totale 3.538
Nome #
Cytotoxic activity of the casein kinase 2 inhibitor CX-4945 against T-cell acute lymphoblastic leukemia: targeting the unfolded protein response signaling 194
Erucylphosphohomocholine, the first intravenously applicable alkylphosphocholine, is cytotoxic to acute myelogenous leukemia cells through JNK- and PP2A-dependent mechanisms. 179
The Akt/mammalian target of rapamycin signal transduction pathway is activated in high-risk myelodysplastic syndromes and influences cell survival and proliferation. 174
The cyclin-dependent kinase inhibitor roscovitine and the nucleoside analog sangivamycin induce apoptosis in caspase-3 deficient breast cancer cells independent of caspase mediated P-glycoprotein cleavage: implications for therapy of drug resistant breast cancers. 152
Metabolism and signaling activities of nuclear lipids. 150
Caspase-9 is the upstream caspase activated by 8-methoxypsoralen and ultraviolet-A radiation treatment of Jurkat T leukemia cells and normal T lymphocytes 150
Caspase-dependent cleavage of 170-kDa P-glycoprotein during apoptosis of human T-lymphoblastoid CEM cells. 148
Two hits are better than one: targeting both phosphatidylinositol3-kinase and mammalian target of rapamycin as a therapeuticstrategy for acute leukemia treatment 138
Diacylglycerol kinase-theta is localized in the speckle domains of the nucleus. 133
Flow cytometric detection of total and serine 473 phosphorylated Akt. 133
Synergistic cytotoxic effects of bortezomib and CK2 inhibitor CX-4945 in acute lymphoblastic leukemia: turning off the prosurvival ER chaperone BIP/Grp78 and turning on the proapoptotic NF-κB 131
HIV-1 Tat protects CD4+ Jurkat T lymphoblastoid cells from apoptosis mediated by TNF-related apoptosis-inducing ligand 130
Detection of serine 473 phosphorylated Akt in acute myeloid leukaemia blasts by flow cytometry 129
Synergistic induction of apoptosis in human leukemia T cells by the Akt inhibitor perifosine and etoposide through activation of intrinsic and Fas-mediated extrinsic cell death pathways. 125
PI3K paninhibition impairs more efficiently proliferation and survival of T-cell acute lymphoblastic leukemia cell lines when compared to isoform-selective PI3K inhibitors 125
Phosphoinositide 3-kinase/Akt involvement in arsenic trioxide resistance of human leukemia cells. 123
Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor perifosine in acute myelogenous leukemia cells 123
Intranucleolar localization of DNA topoisomerase IIalpha is a distinctive feature of necrotic, but not of apoptotic, Jurkat T-cells. 122
Supravital exposure to propidium iodide identifies apoptosis on adherent cells. 121
The novel Akt inhibitor, perifosine, induces caspase-dependent apoptosis and downregulates P-glycoprotein expression in multidrug-resistant human T-acute leukemia cells by a JNK-dependent mechanism. 121
Deguelin, A PI3K/AKT inhibitor, enhances chemosensitivity of leukaemia cells with an active PI3K/AKT pathway 121
Targeting Signaling Pathways in T-cell acute lymphoblastic leukemia initiating cells 120
Targeting the liver kinaseB1/AMP-activated protein kinasepathway as a therapeutic strategyfor hematological malignancies 119
Therapeutic targeting of Polo-like kinase-1 and Aurora kinases in T-cell acute lymphoblastic leukemia 119
Radiobiologic response of medulloblastoma cell lines: involvement of beta-catenin? 119
Widespread impairment of cell proliferation in the neonate Ts65Dn mouse, a model for Down syndrome. 118
The controversial nuclear matrix: a balanced point of view. 118
The phosphoinositide 3-kinase/AKT1 pathway involvement in drug and all-trans-retinoic acid resistance of leukemia cells. 117
Molecular characterization of protein kinase C-alpha binding to lamin A. 117
Nuclear diacylglycerol kinase-theta is activated in response to nerve growth factor stimulation of PC12 cells. 117
Multidrug resistance-associated protein 1 expression is under the control of the phosphoinositide 3 kinase/Akt signal transduction network in human acute myelogenous leukemia blasts. 117
A combination of temsirolimus, an allosteric mTOR inhibitor, with clofarabine as a new therapeutic option for patients with acute myeloid leukemia. 116
The emerging role of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling network in normal myelopoiesis and leukemogenesis. 114
Antiapoptotic role of p38 mitogen activated protein kinase in Jurkat T cells and normal human T lymphocytes treated with 8-methoxypsoralen and ultraviolet-A radiation. 113
Constitutively active Akt1 protects HL60 leukemia cells from TRAIL-induced apoptosis through a mechanism involving NF-kappaB activation and cFLIP(L) up-regulation. 113
The phosphoinositide 3-kinase/Akt pathway regulates cell cycle progression of HL60 human leukemia cells through cytoplasmic relocalization of the cyclin-dependent kinase inhibitor p27(Kip1) and control of cyclin D1 expression. 113
Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: From biology to therapeutic targeting 112
Improving nelarabine efficacy in T cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathway 109
Application of flow cytometry to molecular medicine: detection of tumor necrosis factor-related apoptosis-inducing ligand receptors in acute myeloid leukaemia blasts. 108
Enhancing radiosensitivity of melanoma cells through very high dose rate pulses released by a plasma focus device. 108
Involvement of the phosphoinositide 3-kinase/Akt signaling pathway in the resistance to therapeutic treatments of human leukemias. 107
Phosphatidylinositol 3-kinase inhibition potentiates glucocorticoid response in B-cell acute lymphoblastic leukemia. 104
Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor (2S)-1-(1H-Indol-3-yl)-3-[5-(3-methyl-2H-indazol-5-yl)pyridin-3-yl]oxypropan2-amine (A443654) in T-cell acute lymphoblastic leukemia. 98
Therapeutic potential of targeting mTOR in T-cell acute lymphoblastic leukemia (Review) 93
Therapeutic targeting of CK2 in acute and chronic leukemias 85
Nuclear translocation of PKC-α is associated with cell cycle arrest and erythroid differentiation in myelodysplastic syndromes (MDSs) 82
Totale 5.678
Categoria #
all - tutte 26.689
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.689


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202168 0 0 0 0 0 0 0 0 0 0 0 68
2021/2022345 7 4 1 26 35 9 7 34 10 17 69 126
2022/20231.568 103 145 57 154 87 261 0 93 622 5 17 24
2023/2024207 24 16 19 3 6 13 26 16 58 4 2 20
2024/2025662 24 12 44 9 54 10 72 59 235 6 68 69
2025/20261.319 77 222 58 49 130 133 284 44 55 158 76 33
Totale 5.678